← Leaderboards
Marc D Porter
University Of Utah
$7,043,381
Attributed
$11,149,243
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,954,739 · 9
FDA$1,194,504 · 1
By mechanism
R01$3,410,948 · 1
U01$2,092,021 · 1
R21$1,645,647 · 4
U18$1,194,504 · 1
R44$1,020,000 · 1
R33$982,782 · 1
Top collaborators
- Sean J Mulvihill8 shared
- Kimberly E. Hanson7 shared
- Jane M. Schuh3 shared
- Courtney L Scaife2 shared
- Karl Sieradzki2 shared
- Lorraine Siperko2 shared
- Jason Gregory Beck1 shared
- Himanshu Sant1 shared
Most similar at University Of Utah
Same institution · by research overlap
- Karl Sieradzki$139,613
- Lorraine Siperko$139,613
- Kimberly E. Hanson$809,397
- Courtney L Scaife$401,671
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingDetectionBaseDesignPerformanceDiagnosticLabelNanoparticleImmunoassaySerumValidationUniversitiesUtahSurfaceSignal TransductionGoldInnovationLaboratoriesTechnologyAntigensPrognosticMonoclonal AntibodiesCostScientist
Grant awards (27)
Fluorescence-solid phase Extraction (F-SPE) Microfluidic Platform for Rapid, Onsite Detection and Identification of PFAS with Machine Learning$1,020,000
R44 · FY2025 · ES
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho$610,286
R01 · FY2018 · AI · contact PI
Field-deployable platform for prognostic hepatic cancer screening in low-resource settings$403,427
UG3 · FY2018 · CA · contact PI
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho$615,752
R01 · FY2017 · AI · contact PI
Field-deployable platform for prognostic hepatic cancer screening in low-resource settings$399,914
UG3 · FY2017 · CA · contact PI
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho$648,901
R01 · FY2016 · AI · contact PI
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho$617,771
R01 · FY2015 · AI · contact PI
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho$918,238
R01 · FY2014 · AI · contact PI
Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection$379,793
U01 · FY2014 · CA · contact PI
Real-time Internal Calibration for Multiplexed Microarray Analysis$180,663
R21 · FY2014 · EB · contact PI
Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection$381,878
U01 · FY2013 · CA · contact PI
Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A$307,490
R33 · FY2013 · CA · contact PI
Real-time Internal Calibration for Multiplexed Microarray Analysis$223,688
R21 · FY2013 · EB · contact PI
Development and Validation of Point-of-Care Tests for Tuberculosis$450,000
U18 · FY2012 · FD · contact PI
Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection$422,216
U01 · FY2012 · CA · contact PI
Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A$334,432
R33 · FY2012 · CA · contact PI
Innovative Assay Development for the Diagnosis of Invasive Aspergillosis$184,369
R21 · FY2012 · AI · contact PI
Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection$437,727
U01 · FY2011 · CA · contact PI
Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A$340,860
R33 · FY2011 · CA · contact PI
Development and Validation of Point-of-Care Tests for Tuberculosis$244,504
U18 · FY2011 · FD · contact PI
Innovative Assay Development for the Diagnosis of Invasive Aspergillosis$229,014
R21 · FY2011 · AI · contact PI
Innovative Approach to Assay Development for the Diagnosis of Invasive Aspergillo$211,583
R21 · FY2011 · AI · contact PI
Development and Validation of Point-of-Care Tests for Tuberculosis$500,000
U18 · FY2010 · FD · contact PI
Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection$470,407
U01 · FY2010 · CA · contact PI
Innovative Approach to Assay Development for the Diagnosis of Invasive Aspergillo$197,492
R21 · FY2010 · AI · contact PI
Nanoporous Gold: Extractive Substrate for High-Speed Ultrasensitive Bioassays$183,247
R21 · FY2010 · AI · contact PI
Nanoporous Gold: Extractive Substrate for High-Speed Ultrasensitive Bioassays$235,591
R21 · FY2009 · AI · contact PI